To elucidate additional downstream targets of FAM83H-AS1, a group recently conducted RNA-seq on a pancreatic cancer cell line with siRNA knockdown of FAM83H-AS1 compared to control and identified gene alterations (78 activated and 68 inhibited targets)27. This evidence concerns the gene SACK1H and familial pancreatic carcinoma.